Industry experts question narrative of corporate retreat from DE&I following pressure from right-wing activists.
ESG ratings and data giant targeted by conservative lobby group over controversy scores for companies operating in Israel.
A number of investors raise concerns over the move, which ends coverage of Palestine and parts of Ukraine.
Proxy advisor supports two resolutions set to go to vote at tech giant next month.
Off-label use and pricing among concerns amid booming market for drugs made by pharma firms such as Novo Nordisk.
Investors talk to RI about how they approach DE&I with US companies following a slowdown in momentum on the topic and some public retreats from commitments.
Consultation by Taskforce on Inequality and Social-related Financial Disclosures (TISFD) shows mixed reaction to proposed framework.
Investors are struggling to source relevant data as corporates and managers remain divided on disclosure rules.
RI's guest columnist makes an urgent case for putting the social back into responsible investing.
It comes as Glass Lewis opposes resolution filed at apparel giant in response to alleged controversies in Cambodia and Thailand.